Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.

EClinicalMedicine(2023)

引用 4|浏览5
暂无评分
摘要
Bayer/Bristol Myers Squibb.
更多
查看译文
关键词
Metastatic colorectal cancer,Microsatellite stable,Mismatch repair-proficient,Nivolumab,Regorafenib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要